Pune, India -- (SBWIRE) -- 04/13/2019 -- The latest report has been added to the wide database of Anticoagulants Market by Infinium Global Research. This report studies the Anticoagulants Market by ROA (oral anticoagulants and injectable anticoagulants), anticoagulant drugs (betrixaban, dabigatran (pradaxa), edoxaban), applications (cardiovascular diseases, coronary artery diseases, cardiac arrhythmia, myocardial infarction) and drug class (factor xa inhibitors, dtis, heparin and vitamin k antagonists) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. Anticoagulants Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the Anticoagulants Market. The global anticoagulant market is projected to grow at a CAGR of 6.9% over the forecast period of 2018-2024.
Ask for Sample PDF of Global Anticoagulants Market Report@ https://www.infiniumglobalresearch.com/reports/sample-request/1369
Anticoagulants Market: Industry Insights
Anticoagulants, also known as blood thinners, is a chemical substance used to avoid or diminish clotting of blood, and extend the clotting time. When platelets stick together and proteins in the blood mix together in order to form a solid mass, during that time blood clots are formed. Usually, blood clots are essential in order to stop external bleeding that is caused due to injury to the skin. At the same time blood clots can block blood circulation this can be risky to the blood vessels. Such kind of blood clots in arteries or blood vessels can cause heart attack and stroke. Anticoagulants are used to treat pulmonary embolism, the restrained risk of stroke, atrial fibrillation and deep vein thrombosis (DVT).
Anticoagulants Market: Drivers and Restraints
Increasing occurrences of heart attacks and stroke are driving the demand for anticoagulants market. As per the Centers for Disease Control and Prevention stroke is the main cause of serious long-term disability. Smoking, diabetes, high cholesterol, obesity, and high blood pressure are the major reasons for stroke. At the time of stroke, the brain does not receive adequate nutrients or oxygen that results in the death of the brain cell. Hence, it needs to be treated and diagnosed quickly by reducing brain damage. Therefore, anticoagulant therapy is used to avoid a stroke in patients having several medical conditions. Besides, growing consciousness regarding therapeutic applications of anticoagulants among the surgeons and physicians is likely to generate growth opportunity for this market during the forecast period. On the contrary, risk connected with the practice of oral anticoagulants and its side-effects may restrain the growth for anticoagulants market.
Request a Discount on Standard Prices of this Premium Report @ https://www.infiniumglobalresearch.com/reports/request-discount/1369
Anticoagulants Market: Segmentation
The global Anticoagulant markets are divided into ROA, anticoagulant drugs, applications, and drug class. Based on the ROA the market is classified into oral anticoagulants and injectable anticoagulants. Based on anticoagulant drugs the market is again classified into betrixaban, dabigatran (pradaxa), edoxaban, rivaroxaban (Xarelto) and eliquis (apixaban). Further, based on the application the segment is bifurcated into cardiovascular diseases, coronary artery diseases, cardiac arrhythmia, myocardial infarction, DVT, and heart valve replacement. Currently, cardiovascular diseases and coronary artery diseases hold the major revenue in the market due to an upsurge in the usage of anticoagulants in the treatment of these conditions is driving the market growth for this segment. On the basis of drug class, the market is separated into factor xa inhibitors, dtis, heparin, and vitamin k antagonists. Heparin is anticipated to hold the largest market share in the market. For rapid anticoagulation, Heparin is used in hospitals. It is an injectable anticoagulant.
Anticoagulants Market: Regional Insights
In terms of geographies, the North America region has dominated the market growth for Anticoagulant markets followed by the Asia Pacific region. In North America region Factors such as the existence of skilled medical experts and advancement in technology drives the demand for Anticoagulant markets. Further, the U.S. contributes to the largest market for anticoagulants followed by Canada in the North America region. In Asia Pacific region due to development in medical infrastructure, increasing awareness regarding the benefits of therapeutic applications of anticoagulants, and growing incidences of cardiovascular disease are some of the supporting factors for the growth of Anticoagulant markets.
Read Detailed Index of full Research Study at https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-anticoagulant-market
Anticoagulants Market: Competitive Analysis
Leading players in Anticoagulant markets are Johnson & Johnson, Sanofi, AstraZeneca, Eli Lilly, Keryx Biopharmaceuticals, LEO Pharma, Pfizer, The Medicines Company, Bayer HealthCare, and BoehringerIngelheim.
Reasons to Buy this Report:
- Comprehensive analysis of global as well as regional markets of the Anticoagulants.
- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.